Patient Insights Board Members
Patient, Advocate, Expert: Our Patient Advocates are compensated consultants that work closely with the Patient Cloud team in reviewing applications and project initiatives to provide comprehensive patient perspective.
Learn more about our Patient Advocates by reading their stories below.
Anne Marie Mercurio
Anne Marie Mercurio was treated for invasive breast cancer in 2006. Anne Marie was appointed to serve as co-chair of the Patient Advocate Committee at SWOG Cancer Research Network (NCI NCTN) and is an inaugural member of its Digital Engagement Committee. She serves on several advisory boards and executive committees at a various NCI designated cancer centers and a number of non-profit organizations across the country.
She reviewers grants for NCI cancer centers and has done reviews for research proposals using other funding Mechanisms. She also reviews manuscripts submitted to the BMJ. In addition to be a patient, Anne Marie was the primary caregiver to her mom who was a metastatic breast cancer patient. That experience has helped her identify areas that require attention to address communication gaps that exist for both patients and caregivers to facilitate shared-decision making that focuses on the needs of the patient with the help of their caregiver(s).
Anne Marie’s focus in the advocacy realm is on clinical trials across the entire spectrum. She works with PI’s in labs across the country to help frame research questions, define realistic and inclusive eligibility criteria, and facilitate accrual across diverse patient populations. She is invested in finding ways to incorporate digital tools and wearables into trial protocols to best capture real world evidence. Anne Marie has been working with the Patient Cloud Design Team at Medidata to bring the voice of the patient to the design team. She believes engaging patients early and often will lead to better trial design and quicker accrual.
MarlaJan Wexler
MarlaJan Wexler is a Registered Nurse, patient living with multiple chronic illnesses, and patient advocate. In her 40+ years, she has received diagnoses of tetralogy of Fallot, Systemic Lupus, Erythematosus, ITP, Behcet’s Disease, breast cancer, cervical cancer, Sjogren’s Syndrome, and more; she’s undergone 6 heart surgeries, a double-mastectomy, and been on chemotherapy for years. She was forced to pause her nursing career in 2012 when lupus began attacking major organs. In an effort to make a difference while out of work, MarlaJan started her blog, Luck Fupus, as a way to document and share the daily and long-term struggles of coping with several illnesses. What started as a journal of sorts, her blog became a place people on the web can go for support, up to date clinical information, advocacy, and a good laugh. She uses her platform to educate, share, and empower patients as they navigate healthcare.
MarlaJan won the 2014 WEGO Health Hilarious Health Activist Award, and from there, her work has snowballed into what it is today. She is a two-time Stanford Medicine X, Healthevoices, and PCORI ePatient Scholar, she’s advocated several times on Capitol Hill, and serves as a patient advisor on a number of boards for life science and pharmaceutical companies. MarlaJan has traveled the world sharing her story and experiences, has given Keynote speeches at several conferences, participated in numerous panels, moderated roundtable discussions, and has been interviewed for both local and national publications and television shows, including The Today Show.
She continues to follow her passion in making this business of being sick more palatable for those with chronic illness to navigate with her funny, witty, no filter, no sugar-coated, pithy style.
marlajan@luckfupus.com
Instagram @marlajan
Twitter @marlajan
Phyllisa Deroze
Phyllisa Deroze is a global diabetes patient advocate and Director of Research at dQ&A. She began blogging almost immediately after being diagnosed with type 2 diabetes in 2011. A year later she founded Black Diabetic Info, a website dedicated to increasing awareness of cultural-competent diabetes information from around the African Diaspora. In 2019, after becoming extremely ill, she learned that she had been misdiagnosed with type 2 diabetes for eight years and was finally given the correct diagnosis—Latent Autoimmune Diabetes in Adults, a form of type 1 diabetes.
Phyllisa has graced the cover of Health Monitor magazine and was featured in Diabetic Living, Diabetes Focus, and other magazines and newsletters. Her passion for diabetes lifestyle advocacy can be seen in her YouTube vlogs, social media posts, in-person workshops, published essays, and keynote speeches that she has given in five countries. She enjoys traveling and writing. Her recent publications include The Daily News Blues (A flash fiction story highlighting the intersectionality of COVID-19, mental health, and diabetes) and Laughing to Keep from Dying: Black Americans with Diabetes in Sitcoms and Comedies (A book chapter that merges theories in Disability Studies and American Humor).
Considered one of the most prolific writers on the representation of diabetes in African American literature and popular culture, Phyllisa builds community through storytelling by drawing on a Ph.D. in English Literature from Pennsylvania State University, a ten year career as a university professor, her Fulbright Scholar expertise, and her own experiences living with diabetes. In 2021, she returned home to South Florida with her husband and daughter after living abroad in the United Arab Emirates and Martinique for seven years. Her motto “Diagnosed Not Defeated” is an inspiration for all.
Instagram: @BlackDiabeticInfo Twitter: @not_defeated Blog: @DiagnosedNotDefeated.com
Dave Bjork
Dave Bjork is a lung cancer patient advocate and research evangelist with more than 25 years of progressive experience in community-building, nonprofit fundraising, and patient engagement and empowerment leadership. He is currently Senior Vice President of Empowerment for GRYT Health, working on a team to provide patient-centric solutions to GRYT Health’s pharmaceutical and healthcare clients’ most challenging problems to help them better address patient needs. Dave is also host of the Research Evangelist Podcast where he interviews people in life sciences doing meaningful work. In addition, he is an advisor to Medidata Solutions where he serves on the Patient Insights Board team to bring the patient voice to the clinical trial experience. Previously Dave spent 8 years leading nonprofit fundraising and advocacy teams, including 4 years as Vice President of Development for National Foundation for Cancer Research where he was responsible for all fundraising and advocacy efforts.
A lung cancer survivor, Bjork has made it his life mission to connect patients, biopharma companies, academic institutions, and other key influencers to forge strong partnerships to focus on research. He also advocates for and builds bridges between patient groups and the biopharma industry. He proudly serves on the Advisory Board of the Cancer Epigenetics Institute at Fox Chase Cancer Center. Dave earned a BS in Economics and Finance from the Wharton School at the University of Pennsylvania.
Justus Harris
Justus Harris (he/they) is a designer, healthcare strategist, and artist with two decades of lived type 1 diabetes experience. His expertise lies at the intersection of data visualization and narratives, enabling him to communicate personal and public health insights effectively. His creations encompass the transformation of medical data into 3D-printed objects, augmented reality experiences, and intuitive 2D designs. Features include the Kennedy Center as a Citizen Artist Fellow, Stanford Medicine X as an ePatient Scholar, and TEDx as a speaker.
His clients range from data-driven health companies such as Teledoc (formerly Livongo), One Drop, and Medidata as a Patient Insights Board member.
As an advocate, Justus is committed to helping improve the lives of patients in the ongoing COVID pandemic, patients without access to affordable treatments, and LGBTQIA+ individuals in the EU and United States.
Linnea Olson was a founding member of what would become Medidata’s Patient Insights Board. Linnea lived with lung cancer for nearly 17 years prior to her death in November of 2021. She blazed a trail by participating in SIX phase I clinical trials, the first one in 2008 when there were no further traditional treatment options available. This came at a time when lung cancer research was at a tipping point and her doctors identified that Linnea had an ALK mutation for which they were testing new treatments. As she said, “… when you’re chased by a bear to the edge of a cliff, you jump.” Linnea jumped. Six Times. Her participation in each trial added to new, approved lines of novel therapeutics. Linnea’s ability to eloquently and generously share her experiences and to push back when something seemingly didn’t best serve the needs of patients was unparalleled. To honor her extraordinary life and to ensure her legacy lives on, Medidata established the Linnea Olson Award for Patient Advocacy in 2022 which was awarded to Linnea posthumously, as the inaugural recipient.
In her own words, her TEDx talk from November 2019:
Patient, parent, person, research subject | Linnea Olson | TEDxBeaconStreet
Here are just a few of the many tributes and expressions of appreciation:
Sheila Johnson – In Memoriam
Sheila Marie Johnson began working with Medidata in November of 2020 months before the patient advocate consultants would be formalized as the Patient Insights Board. Sheila served in the US Air Force for decades before a diagnosis of metastatic breast cancer forced her into retirement. She was in treatment for fourteen years before her death in April of 2024. Sheila was especially passionate about making sure minority and underrepresented communities understood the importance of their participation in research. Sheila approached every interaction with kindness and joy. Despite her many accomplishments, she was filled with humility and she always expressed genuine amazement that her advocacy work was of such enormous impact. Sheila enrolled in an early phase trial for the drug, Enhertu which quickly changed the trajectory of treatments for people with HER2+ breast cancer. Her book, A Survivor’s Lens was adapted for the BET+ movie, God’s Grace: The Sheila Johnson Story. Always quick to offer assistance, to share her story, or do anything that would be helpful, Sheila’s legacy, in her own words will live on, “Sheila tried. Sheila cared. And Sheila did everything she could to end breast cancer once and FOR ALL.”
In October of 2023, just six months before her death, the movie was released and she was featured on the local news:
Black woman fighting decade-long battle with breast cancer advocates for others with the disease